Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.13%34.99B | 10.38%133.9B | 11.63%100.52B | 14.51%71.55B | 7.82%32.97B | -2.38%121.3B | 0.73%90.04B | 2.94%62.49B | 4.93%30.58B | 1.05%124.25B |
| Operating income | 6.13%34.99B | 10.38%133.9B | 11.63%100.52B | 14.51%71.55B | 7.82%32.97B | -2.38%121.3B | 0.73%90.04B | 2.94%62.49B | 4.93%30.58B | 1.05%124.25B |
| Operating expenses | -15.81%-25.09B | -24.01%-93.39B | -30.08%-69.81B | -29.86%-48.33B | -22.13%-21.67B | -3.59%-75.31B | -6.58%-53.67B | -7.98%-37.22B | -9.69%-17.74B | 5.86%-72.7B |
| Gross profit | -12.44%9.89B | -11.92%40.5B | -15.58%30.71B | -8.11%23.22B | -11.97%11.3B | -10.79%45.99B | -6.82%36.38B | -3.69%25.27B | -1.02%12.83B | 12.73%51.55B |
| Selling expenses | 12.33%-2.02B | -3.63%-9.22B | 1.50%-6.25B | -5.21%-4.38B | -13.78%-2.3B | 12.05%-8.9B | 8.00%-6.35B | 9.74%-4.17B | 6.95%-2.02B | -10.31%-10.12B |
| Administrative expenses | -20.48%-1.14B | 5.75%-4.22B | 10.77%-2.88B | 4.76%-2.13B | 16.97%-943.88M | 20.50%-4.48B | 15.13%-3.23B | 11.09%-2.24B | 13.72%-1.14B | -5.61%-5.63B |
| Research and development expenses | 17.50%-4.91B | 5.31%-22.75B | 4.44%-17.81B | 0.48%-12.66B | 6.73%-5.95B | 4.97%-24.03B | 2.20%-18.64B | 0.51%-12.73B | -7.46%-6.38B | -17.07%-25.29B |
| Profit from asset sales | --8.61M | -94.74%5.03M | -95.13%4.26M | -94.29%3.85M | ---- | 364.43%95.66M | 330.90%87.48M | 309.22%67.37M | -50.84%3.86M | 86.75%20.6M |
| Revaluation surplus | -152.99%-80.65M | 116.25%101.6M | 148.16%203.33M | 138.27%159.4M | 188.86%152.21M | 10.99%-625.13M | -136.31%-422.19M | 3.35%-416.54M | 35.62%-171.3M | 38.50%-702.28M |
| -Changes in the fair value of other assets | -152.99%-80.65M | 116.25%101.6M | 148.16%203.33M | 138.27%159.4M | 188.86%152.21M | 10.99%-625.13M | -136.31%-422.19M | 3.35%-416.54M | 35.62%-171.3M | 38.50%-702.28M |
| Impairment and provision | -98.96%-392.55M | 37.39%-526.37M | 60.88%-300.06M | 23.91%-400.14M | 51.99%-197.3M | 10.00%-840.73M | 36.07%-766.96M | -15.50%-525.87M | 19.76%-410.97M | 40.09%-934.16M |
| -Other impairment is provision | -98.96%-392.55M | 37.39%-526.37M | 60.88%-300.06M | 23.91%-400.14M | 51.99%-197.3M | 10.00%-840.73M | 36.07%-766.96M | -15.50%-525.87M | 19.76%-410.97M | 40.09%-934.16M |
| Special items of operating profit | -3.75%778.59M | 9.66%3.34B | 21.21%2.64B | 20.20%1.94B | 11.60%808.97M | 90.21%3.05B | 218.20%2.18B | 205.33%1.62B | 35.47%724.9M | -46.29%1.6B |
| Operating profit | -26.74%1.88B | -32.41%6.14B | -35.01%5.45B | -18.19%5.17B | -18.38%2.57B | -0.87%9.08B | 9.87%8.38B | 19.57%6.32B | 7.56%3.15B | 2.22%9.16B |
| Financing income | -49.49%808.38M | -1.19%4.35B | -2.76%3.46B | -1.14%2.55B | 15.24%1.6B | 7.68%4.4B | 19.23%3.55B | 40.33%2.58B | 60.24%1.39B | 67.41%4.08B |
| Financing cost | 41.00%-724.97M | -8.62%-3.74B | 3.22%-2.84B | 15.09%-2.02B | -1.22%-1.23B | -9.72%-3.45B | -15.76%-2.94B | -44.52%-2.38B | -71.87%-1.21B | -61.44%-3.14B |
| Special items of earning before tax | -370.12%-41.74M | 47.64%-58.94M | 366.16%64.27M | 13,898.50%45.95M | 262.44%15.45M | -103.80%-112.58M | 56.48%-24.15M | 99.23%-333K | 59.00%-9.51M | -27.93%-55.24M |
| Earning before tax | -48.70%1.5B | -31.71%6.3B | -30.75%5.9B | -9.76%5.66B | -8.68%2.93B | -9.54%9.23B | 0.74%8.52B | 3.60%6.28B | 3.80%3.21B | 16.59%10.2B |
| After-tax profit from continuing operations | -46.50%1.32B | -33.40%5.57B | -31.89%5.34B | -11.45%5.06B | -10.76%2.46B | -9.58%8.36B | 1.16%7.85B | 5.90%5.71B | 5.64%2.76B | 18.60%9.24B |
| Earning after tax | -46.50%1.32B | -33.40%5.57B | -31.89%5.34B | -11.45%5.06B | -10.76%2.46B | -9.58%8.36B | 1.16%7.85B | 5.90%5.71B | 5.64%2.76B | 18.60%9.24B |
| Minority profit | -28.86%7.79M | 23.86%-52.67M | 138.24%22.69M | 95.52%-988K | -45.83%10.95M | 18.52%-69.18M | 29.65%-59.34M | 72.40%-22.06M | 170.95%20.21M | 70.59%-84.9M |
| Profit attributable to shareholders | -46.58%1.31B | -33.32%5.62B | -32.69%5.32B | -11.77%5.06B | -10.50%2.45B | -9.66%8.42B | 0.83%7.91B | 4.76%5.73B | 3.74%2.74B | 15.41%9.33B |
| Basic earnings per share | -47.06%0.27 | -33.52%1.17 | -32.73%1.11 | -11.67%1.06 | -10.53%0.51 | -10.20%1.76 | 0.00%1.65 | 4.35%1.2 | 1.79%0.57 | 14.62%1.96 |
| Diluted earnings per share | -47.06%0.27 | -34.09%1.16 | -32.73%1.11 | -11.67%1.06 | -10.53%0.51 | -10.20%1.76 | 0.00%1.65 | 4.35%1.2 | 1.79%0.57 | 14.62%1.96 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming Accounting Firm | -- | -- | -- | Ernst & Young Huaming Accounting Firm | -- | -- | -- | Ernst & Young Huaming Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.